Susquehanna International Group, LLP Merck & Co., Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 697,604 shares of MRK stock, worth $79.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

697,604

Previous 1,175,088 40.63%

Holding current value

$79.3 Million

Previous $155 Million 44.3%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$123.8 - $132.96 $59.1 Million - $63.5 Million	-477,484 Reduced 40.63%	697,604 $86.4 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $18.5 Million - $21.5 Million	162,972 Added 16.1%	1,175,088 $155 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $49.8 Million - $54.2 Million	-497,369 Reduced 32.95%	1,012,116 $110 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $8.15 Million - $9.05 Million	79,153 Added 5.53%	1,509,485 $155 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $78.9 Million - $86 Million	-726,296 Reduced 33.68%	1,430,332 $165 Million
Q1 2023 May 16, 2023	BUY	$102.94 - $114.86 $110 Million - $123 Million	1,070,134 Added 98.49%	2,156,628 $229 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $61.2 Million - $78.4 Million	699,435 Added 180.71%	1,086,494 $121 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $8.68 Million - $9.75 Million	-102,724 Reduced 20.97%	387,059 $33.3 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $34.8 Million - $39.5 Million	-417,133 Reduced 45.99%	489,783 $44.7 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $91.5 Million - $103 Million	-1,244,693 Reduced 57.85%	906,916 $74.4 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $166 Million - $208 Million	-2,301,093 Reduced 51.68%	2,151,609 $165 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $43.8 Million - $48.2 Million	610,949 Added 15.9%	4,452,702 $334 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $29.1 Million - $32.2 Million	413,741 Added 12.07%	3,841,753 $299 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $116 Million - $137 Million	1,685,253 Added 96.7%	3,428,012 $264 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $23.4 Million - $26 Million	326,103 Added 23.02%	1,742,759 $143 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $12.5 Million - $14.2 Million	171,111 Added 13.74%	1,416,656 $118 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $55 Million - $62.5 Million	780,498 Added 167.83%	1,245,545 $96.3 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $17.6 Million - $24.4 Million	-277,743 Reduced 37.39%	465,047 $35.8 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $47.7 Million - $53.9 Million	615,378 Added 482.98%	742,790 $67.6 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $3 Million - $3.27 Million	39,491 Added 44.92%	127,412 $10.7 Million
Q2 2019 Aug 16, 2019	BUY	$69.84 - $81.59 $4.95 Million - $5.78 Million	70,836 Added 414.61%	87,921 $7.37 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $1.64 Million - $1.92 Million	-23,500 Reduced 57.9%	17,085 $1.43 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $26 Million - $30.5 Million	-511,023 Reduced 92.64%	40,585 $2.46 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $11.6 Million - $13.5 Million	228,139 Added 70.53%	551,608 $30 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $22.1 Million - $26.4 Million	-428,834 Reduced 57.0%	323,469 $18.2 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $44.1 Million - $47.5 Million	752,303	752,303 $48.2 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Merck & Co., Inc. Transaction History